Ƶ

More Mounjaro Doses Limited; At-Home Menopause Tests? Kimchi for Lower Obesity Risk

— News and commentary from the endocrinology world

Ƶ MedicalToday
Endo Break over a computer rendering of a man with illustrated body organs.

All (Mounjaro) -- 10, 12.5, and 15 mg -- will be in short supply through early March due to increased demand. Lower doses should still be available, according to the FDA.

But of weight-management drugs give employers more time to figure out how to cover these pricey treatments. (Wall Street Journal)

What's the value in ? (Washington Post)

Eating was linked with a higher incidence of type 2 diabetes, cardiovascular disease, diabetes-related cancer, and death. (The Lancet Diabetes & Endocrinology)

Bariatric surgery had the strongest and most consistent association with decreased incidence of breast, ovarian, and endometrial cancers, according to a review.

Genetic tests may help figure out which patients should get which . (Axios)

People with diabetes taking GLP-1 receptor agonists were less likely to be data from Epic Research suggested. The findings come shortly after the FDA's preliminary review that turned up no evidence linking this class of agents to suicidal thoughts.

Abbott launched a for people taking GLP-1 agents, undergoing weight-loss surgery, or following a calorie-restricted diet who are concerned about muscle loss.

Up to per day were linked with a lower risk of obesity in Korean men. (BMJ Open)

The proposed that nine per- and polyfluoroalkyl substances (PFAS) chemicals be categorized as hazardous to human health.

Novo Nordisk's parent company will buy Catalent in a $16.5 billion deal that could help . (CNBC)

Stakeholder organizations to "ensure that Americans living with obesity have the same respect, attention, and medical care for their disease as those with other chronic conditions."

increased physical activity, especially in girls, an Australian study showed. (International Journal of Behavioral Nutrition and Physical Activity)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.